Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.02

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of ($0.02). Revenue for the quarter came in at $10.8 million, versus $0 reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Seaport Global Securities Downgrades JetBlue Airways (JBLU) to Neutral
• Bitmine reports 5.82 million ETH holdings, $11.4B total assets
• Zhibao Technology closes $154.7M PIPE deal paid in Bitcoin